Resources

Pension reform unlocks cash for UK life sciences, London Life Sciences Week and #bioProcessUK are here.

New data shows investing in life sciences produces great returns, London Life Sciences Week and #bioProcessUK are nearly here.

The Chancellor’s Autumn Budget placed life sciences at the forefront of the UK’s growth agenda, providing key support for R&D tax relief, medicines manufacturing, and sector-specific financing through the British Business Bank.

In his latest blog, Dr Martin Turner, BIA’s Associate Director of Policy, Public Affairs & Investor Relations, explores the Chancellor’s Autumn Budget 2024, which prioritises life sciences as a key growth driver within the UK economy. Martin provides an insightful breakdown of the measures, from R&D tax relief to funding boosts in manufacturing and biotech. Read on to discover the budget highlights and what they mean for life sciences in the UK.

We are excited to welcome the newly elected members of the BIA Board of Directors, who will bring fresh insights and expertise to help drive our mission forward. Nick Gardiner shares his perspective on the importance of these appointments and the unique value each new Director brings to the BIA.

In response to the global rise in demand for innovative therapies, the development and production of novel biopharmaceuticals continue to expand.

The first Budget of the new government will be presented this Wednesday. It’s an important moment, not just for life sciences but for the broader UK economy. Read this blog for an update on the Life Sciences Council, and the launch of our latest Influencing and shaping our sector report.

Attending the BIA’s TechBio UK conference this year offered an incredible opportunity to witness the ingenuity and innovation driving the future of life sciences.

Read today's blog to learn about our latest reports, upcoming events and our CEO's thoughts on the upcoming budget.

This is part of a series of blogs focussing on hearing therapeutics from different sector perspectives. In this blog, Karen Steel shares her thoughts on what she perceives to be some of the biggest opportunities in relation to the development of new treatments for hearing loss.

Today marks a pivotal moment for our Association as a key strategic objective has been realised: the new government has placed growth at the centre of its agenda, with life sciences positioned as a cornerstone of that plan.

In this blog, Izzy Webb outlines why the UK has published voluntary guidance to promote synthetic nucleic acid screening and who the guidance is intended for.

In this insightful blog, Louis Taylor, CEO of the British Business Bank, explores how the Mansion House reforms and increased pension fund investments could unlock billions in domestic capital, fueling the next generation of UK innovators.

The government's plan to put life sciences up in lights this Sunday ahead of the International investment Summit was somewhat overtaken by the news of the reorganisation of Keir Starmer's Number 10 team which dominated headlines. Nevertheless, it's been a busy week of announcements affecting our sector.

The BIA’s policy and public affairs team attended the conferences of the three major UK parties this year. This is a key point in the political calendar and allows us to highlight the sector through fringe events, meet policymakers, and get a sense of the political environment.

Dr Peter Bloomfield is the Director of Research at the Macular Society. In this guest blog, he lays out the problem posed by macular disease and his hope for a solution. He also gives insight into why the Macular Society joined the BIA.

In this blog, Albert Maguire-King, Media and Communications Executive at the BIA, recaps the recent Women in Biotech event in Manchester, where industry leaders discussed talent attraction, female leadership, and career advancement. The panel highlighted the importance of fostering home-grown talent, supporting female role models, and offering mentorship opportunities.

The shape of the political landscape that our sector will navigate this year became clear at the Labour Party conference in Liverpool last week. The new Labour government will unveil its industrial strategy, hold a Global Investment Summit, and meet with the Life Science Council before the key moment of the Budget on 30 October.

In this blog, the BIA's Senior Policy and Public Affairs Manager, Dr Emma Lawrence, discusses the life science implications of Lord Darzi's review.

In this blog, Albert Maguire-King, Media and Communications Executive at the BIA, discusses the recent Techbio Boost event hosted by KQ Labs and the BIA, highlighting the programme's role in supporting the growth of London-based techbio seed and pre-series A companies.